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The CNS abundantly expresses P2X receptor channels for ATP;
of these the most widespread in the brain is the P2X4 channel.
We show that ivermectin (IVM) is a specific positive allosteric
effector of heterologously expressed P2X4 and possibly of het-
eromeric P2X4/P2X6 channels, but not of P2X2, P2X3, P2X2/
P2X3, or P2X7 channels. In the submicromolar range (EC50,
;250 nM) the action of IVM was rapid and reversible, resulting
in increased amplitude and slowed deactivation of P2X4 chan-
nel currents evoked by ATP. IVM also markedly increased the
potency of ATP and that of the normally low-potency agonist
a,b-methylene-ATP in a use- and voltage-independent manner
without changing the ion selectivity of P2X4 channels. There-
fore, IVM evokes a potent pharmacological gain-of-function
phenotype that is specific for P2X4 channels. We also tested
whether IVM could modulate endogenously expressed P2X
channels in the adult trigeminal mesencephalic nucleus and
hippocampal CA1 neurons. Surprisingly, IVM produced no sig-
nificant effect on the fast ATP-evoked inward currents in either
type of neuron, despite the fact that IVM modulated P2X4
channels heterologously expressed in embryonic hippocampal
neurons. These results suggest that homomeric P2X4 channels
are not the primary subtype of P2X receptor in the adult trigem-
inal mesencephalic nucleus and in hippocampal CA1 neurons.
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ATP functions as a neurotransmitter in the nervous system
(Burnstock, 1972), in which it can mediate (Edwards et al., 1992;
Evans et al., 1992; Bardoni et al., 1997; Nieber et al., 1997;
Pankratov et al., 1998; Jo and Schlichter, 1999) and possibly
modulate fast synaptic transmission (Gu and MacDermott, 1997;
Khakh and Henderson, 1998a). Furthermore, a class of ion chan-
nels exists that is a major target for synaptically released ATP;
these are the P2X receptor channels. P2X receptors are ATP-
gated, nonselective cation channels (Surprenant et al., 1995), and
they comprise a family of seven distinct subunits that can form
functional channels when heterologously expressed (for review,
see North, 1996; Ralevic and Burnstock, 1998). Of these, P2X4
receptor channels are notable because they are widely expressed
in the brain (Buell et al., 1996; Collo et al., 1996), they form
functional channels that can be both homomeric and heteromeric
(Buell et al., 1996; Collo et al., 1996; Seguela et al., 1996; Soto et
al., 1996; Le et al., 1998a), and they clearly can be localized to
certain neurons (Le et al., 1998b). P2X4 receptors have thus been
presumed to be an important target for endogenously released
ATP. However, previously there has been no way to specifically
probe P2X4 channels, and this represented a considerable hin-
drance to investigating both their existence and pathophysiolog-
ical roles in native systems. As a consequence, the prevalence and
function of P2X4 channels in brain neurons remained largely
uninvestigated.
Many ligand-gated ion channels are allosterically modulated
(Li et al., 1997; Changeux and Edelstein, 1998), and such alloste-
ric interactions can be starting points for rational drug design.
Moreover, some P2X receptor channels are modulated by cations,
e.g., P2X2 and P2X3 channels by Zn
21, Ca 21, and H1 (King et
al., 1997; Stoop et al., 1997; Wildman et al., 1997, 1998; Cook et
al., 1998). There is also evidence that an allosteric interaction at
P2X4 channels regulates agonist binding (Michel et al., 1997), and
recent work demonstrates that ATP receptor antagonists can also
potentiate ATP-evoked currents at P2X4 channels (Bo et al.,
1995; Miller et al., 1998); however, the mechanism(s) and conse-
quences for P2X4 channel properties remain to be fully explored.
Furthermore, such compounds are of limited value to probe P2X4
channels, because they are antagonists of most other ATP recep-
tors, they potently inhibit ATP-hydrolyzing enzymes, and some
are chemically impure (see Humphrey et al., 1995).
Ivermectin (IVM) is an agonist of glutamate-gated chloride
channels of invertebrates from several phyla (Cully et al., 1994),
and this is thought to be its mechanism of action when used
clinically as a treatment for river blindness caused by the nema-
tode Onchocerca volvulus (Fisher and Mrozik, 1992; Van Laet-
hem and Lopez, 1996). Recent evidence shows that in addition to
its action on glutamate-gated chloride channels, IVM can also
allosterically modulate mammalian GABAA (Krusek and
Zemkova, 1994) and a7 nicotinic channels (Krause et al., 1998),
and this prompted us to test its actions on P2X channels.
MATERIALS AND METHODS
Molecular biology. Wild-type P2X2, P2X3, P2X4, and P2X7 cDNAs cloned
into pcDNA3 or pcDNA1 were obtained from Glaxo Wellcome (Green-
ford, Middlesex, UK). cDNAs were linearized at unique restriction sites
downstream of the poly(A) tail. The cDNAs were transcribed in vitro
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using the mMESSAGE mMACHINE kit (Ambion Inc., Austin, TX).
The capped cRNA was dissolved in DEPC-treated water at a concen-
tration of ;1 mg/ml and stored at 280°C until required in 2 ml aliquots.
Five to 10 ng of cRNA were injected into individual Xenopus laevis
oocytes in a volume of 50 nl /oocyte using a Drummond micropipettor
(Quick and Lester, 1994); the preparation and maintenance of the
oocytes was performed as described previously (Quick and Lester, 1994),
and all electrophysiological recordings were made 1–4 d after injection.
Oocyte studies. Two-electrode voltage-clamp recording of oocytes was
performed using the Geneclamp 500 amplifier (Axon Instruments, Foster
City, CA). Electrodes were pulled (Flaming–Brown type horizontal
puller; Sutter Instruments, Novato, CA) from borosilicate glass (Sutter
Instruments) and back-filled with 3 M KCl to yield resistances of 1–2 MV.
Recordings were made in solution consisting of (in mM): 98 NaCl, 5
HEPES, and 1 MgCl2, pH 7.45, which was superfused over the oocytes
by gravity flow at a rate of ;3 ml/min (chamber volume was ;300 ml).
Solutions containing ATP were applied to the oocyte using a solenoid-
operated solution switcher (General Valve Co., Fairfield, NJ); complete
solution exchange around the oocyte occurred within 0.5–1.0 sec. We
used IVM at a concentration of #10 mM, because at higher concentra-
tions we occasionally observed some precipitation in physiological solu-
tions. The vehicle for IVM is DMSO. In vehicle controls 1% DMSO did
not affect ATP-evoked currents (control 100 mM ATP-evoked current
was 22611 6 186 nA, whereas in the presence of 1% DMSO it was
22789 6 69 nA; p . 0.05; n 5 4; also see Results). Voltage control of
oocytes was maintained using a Digidata 1200 interface and a personal
computer running pCLAMP 6 or pCLAMP 7 software (Axon Instru-
ments). Data were filtered at 200–500 Hz and digitized at three to five
times this rate. Current–voltage relation data were filtered at 1 kHz and
digitized at 3 kHz. All experiments were performed at 20–23°C.
Human embryonic kidney cells. Human embryonic kidney (HEK) 293
cells were transfected using Superfect (Qiagen, Hilden, Germany), and
all recordings were made 24–48 hr later using an Axoclamp 2A amplifier
(Axon Instruments). The extracellular recording solution used for mam-
malian cells comprised (in mM): 147 NaCl, 2 KCl, 1 MgCl2, 2.5 CaCl2,
10 HEPES, and 10 dextrose, and the pipette solution comprised (in mM):
154 NaCl (or KCl), 11 EGTA, and 10 HEPES. Whole-cell voltage-clamp
recordings were made with 5 MV borosilicate glass electrodes (Sutter
Instruments) using methods that are essentially identical to those already
described (Evans et al., 1996).
Adult rat brain slices. All methods used were similar to those already
described previously for brainstem neurons (Khakh et al., 1997; Khakh
and Henderson, 1998a,b) and hippocampal neurons (Dunwiddie et al.,
1997; Frazier et al., 1998a,b). Briefly, young (18- to 27-d-old) male
Sprague Dawley rats were killed by decapitation, and a vibratome (model
1000; Pelco, Clovis, CA) was used to prepare 300-mm-thick coronal slices
of hippocampus and brainstem. During incubation the slices were sub-
merged at 32–34°C in artificial CSF comprising (in mM): 124 NaCl, 3.3
KCl, 2.4 MgSO4, 10 D-glucose, 2.5 CaCl2, 1.2 KH2PO4, and 25.9
NaHCO3 saturated with 95% O2 and 5% CO2 gas. All experiments were
performed at 32–34°C while the tissue was superfused with buffer at a
rate of 2 ml/min. Whole-cell patch-clamp recording was accomplished by
using glass pipettes pulled using a Flaming–Brown electrode puller. The
resistance of the pipettes was 6–10 MV when filled with a potassium
gluconate-based internal solution, which comprised (in mM): 130 K
gluconate, 1 EGTA, 2 MgCl2, 0.5 CaCl2, 2.5 ATP, 0.3 GTP, and 10
HEPES, pH 7.25, adjusted to 290 mOsm. Cells were visualized with an
upright microscope (AxioSkop; Zeiss, Thornwood, NY) equipped with
differential interference contrast optics. Puffs (5–20 msec) of ATP (50
mM) were applied directly to the cell body via pressure microejection
(5–20 psi) from pipettes identical to the recording pipettes, using a
Picospritzer II (General Valve, Fairfield, NJ). Inward currents were
recorded in neurons voltage-clamped at 250 to 260 mV using HEKA
(Aalen, Germany) software and hardware. Calibrated syringe pumps
(Razel, Stamford, CT) were used to add IVM from a concentrated stock
solution directly to the superfusion system. Trigeminal mesencephalic
nucleus (MNV) neurons were identified by their location (lateral to the
locus coeruleus and the fourth ventricle), large pseudomonopolar ap-
pearance, and prominent IH current (Khakh et al., 1997; Khakh and
Henderson, 1998b). CA1 pyramidal cells were identified on the basis of
their anatomical location, long dendrite projecting into the stratum
radiatum, and distinctive electrophysiological characteristics (Dunwiddie
et al., 1997; Frazier et al., 1998a,b).
Embryonic hippocampal neurons. Neurons were prepared as described
(Li et al., 1998). Hippocampal neuron cultures were transfected with
plasmids for P2X4 and for enhanced green fluorescent protein (EGFP)
using the Bio-Rad (Hercules, CA) Helios gene gun. Gold particles coated
with plasmids were prepared as recommended by the manufacturer, and
the gene gun was pressurized between 60 and 100 psi. Neurons were
transfected after 14 d in culture, and recordings were made 24–48 hr
later. Recordings were made using borosilicate glass electrodes of 4–7
MV resistance. The bath solution was (in mM): 110 NaCl, 5.4 KCl, 1.8
CaCl2, 0.8 MgCl2, 10 HEPES, and 10 D-glucose, pH 7.4, osmolarity 230
mOsm. Patch pipettes were filled with a solution containing (in mM): 100
potassium gluconate, 0.1 CaCl2, 1.1 EGTA, 5 MgCl2, 10 HEPES, 3 ATP,
3 phosphocreatine, and 0.3 GTP, pH 7.2, 215 mOsm. Whole-cell voltage
clamp was maintained using an Axopatch-1D amplifier controlled by a
personal computer running pCLAMP 6 software via a Digidata 1200
interface (Axon Instruments). Data were filtered at 2 kHz, digitized at 5
kHz, and recorded on computer for later analysis. Drugs were applied to
single voltage-clamped neurons using a U-tube concentration clamp
system (Khakh et al., 1995a,b).
Data analysis. Data were analyzed using Clampfit (Axon Instruments)
or Origin 5.0 (Microcal Software Inc., Northampton, MA). Data in the
text and graphs are shown as mean 6 SEM from n determinations as
indicated (always more than four experiments). All current–voltage
relations shown in the figures are leak-subtracted. The ratio of NMDG 1
to Na 1 permeability was calculated for control ATP-evoked currents and
those in the presence of IVM using the relation,
pNMDG1
pNa1 5 expSDErev FRT D ,
where pNMDG 1 is the permeability to NMDG 1, pNa 1 is the perme-
ability to Na 1, DErev is the shift in reversal potential, and F, R, and T
have their usual meaning (Khakh et al., 1999). Concentration–effect
curves were fitted where appropriate, as indicated, to the Hill equation of
the form,
y 5 1
1
1 1 SEC50@A# D
nH2 ,
where y is current evoked by ATP, EC50 is the response producing 50%
of the maximal response, nH is the Hill coefficient, and [A] is the
concentration of ATP. Membrane capacitance was determined from the
capacitive transients produced by 5–10 mV steps of .200 msec duration
using the membrane test capability of pCLAMP 7 (Axon Instruments).
Mean data in Figure 3A were fitted to exponential functions (Origin 5.0)
to determine time constants for association (ton) and dissociation (toff).
The equilibrium dissociation constant (kd) for the receptor–IVM inter-
action was determined by considering the interaction of IVM with P2X4
channels by the following reaction scheme:
A 1 R -|0
k11
k21
AR,
where
1
ton
5 k11@A# 1 k21,
1
tof f
5 k21
and
kd 5
k21
k11
,
where the forward binding rate constant is k11, [A] is the concentration
of IVM used, and k21 is the rate constant for dissociation. Total charge
transfer during ATP-evoked currents was determined by integration of
the voltage-clamp records. In some of the figures background noise has
been minimized in the original traces by use of a Savitsky–Golay digital
smoothing paradigm (Origin 5.0). Statistical tests were performed using
the paired or unpaired Student’s t test, as appropriate, and p , 0.05 was
taken to indicate significance.
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RESULTS
IVM potentiates P2X4 but not P2X2, P2X3, P2X2/P2X3,
or P2X7 channel currents
We expressed homomeric P2X4 channels in Xenopus oocytes and
tested for responses to ATP applications (5–20 sec in duration).
Suramin (30 mM), which is an antagonist of some types of P2X
ATP receptors, did not inhibit peak currents evoked by 100 mM
ATP at P2X4 channels (n 5 4). However, suramin blocked by
.80% the current evoked by 100 mM ATP at both P2X2 and P2X3
channels (Fig. 1; also see Buell et al., 1996; Seguela et al., 1996).
We next tested the action of IVM (10 mM) on currents evoked by
ATP (100 mM) at P2X2, P2X3, P2X2/P2X3, P2X4, and P2X7
channels. In cells expressing P2X2, P2X3, or P2X2/P2X3 channels,
IVM produced no significant effect on ATP-evoked currents (Fig.
1); however, in P2X4-expressing cells, IVM increased the peak
ATP-evoked current significantly in all cells tested (by 50–300%
depending on the concentration and incubation time; see below).
ATP-evoked currents at P2X7 channels expressed in oocytes have
two phases (Nuttle and Dubyak, 1994; Khakh et al., 1999), and we
tested whether IVM could affect either phase of these currents
evoked by ATP at P2X7 channels. Neither phase of the 100 mM
ATP-evoked current at P2X7 channels was potentiated by IVM
(10 mM); the initial current and secondary current peaks were
2512 6 76 and 27490 6 538 nA for ATP alone and 2371 6 108
and 25257 6 945 nA for ATP plus IVM, respectively (n 5 3;
unpaired Student’s t test, p . 0.05). Homomeric P2X1 and P2X5
channel assemblies were not tested for IVM sensitivity.
Functional consequences of P2X4 channel
allosteric modulation
IVM (3 mM) produced a maximal potentiation of ATP-evoked
currents at P2X4 channels within 30 sec of application with a time
constant (ton) of 14 sec (Fig. 2A; the apparent bimolecular rate
constant for association was 2.2 3 104 M/sec). The potentiation by
IVM was fully reversible within 10 min of washing with a time
constant (toff) of 165 sec. The data presented in Figure 2 show
that the action (and reversal) of IVM is use-independent, sug-
gesting that permeation through open P2X channels is not re-
quired. The action of IVM depends on concentration, with an
apparent half-maximal effect (EC50) at ;257 nM (for currents
evoked by 3 mM ATP), which is in good agreement with a kd of
278 nM determined from kinetic experiments shown in Figure 2,
A and B (see Data analysis). However, the IVM concentration–
effect relationship did not reach a well defined plateau at high
concentration (Fig. 2C), vitiating a systematic description in terms
of the Hill function or other dose–response formulations. With
IVM at concentrations $10 mM we observed a downward phase
of the concentration–effect relationship, and this may represent
increased desensitization of P2X4 channels during ATP applica-
tion. Importantly, the augmentation by IVM is not attributable to
DMSO, because DMSO caused no marked change in the ATP-
evoked current when it was added to the buffer at 0.1% (control
current evoked by ATP was 2181 6 54 nA, whereas in the
presence of DMSO it was 2167 6 91 nA), but 1 mM IVM
solutions also contained 0.1% DMSO and produced a large in-
crease in ATP-evoked current (Fig. 2C).
In control cells P2X4 channels responded to ATP with an EC50
of 3 mM (Khakh et al., 1999), with a maximal current of ;2 mA.
However, in oocytes pretreated with 3 mM IVM for 2 min before
each application of ATP, the EC50 was 0.3 mM, and the maximal
current increased to ;4 mA (Fig. 2D). This profile of action is
similar to the effect of IVM on a7 nicotinic channels (Krause et
al., 1998) and indicates an allosteric action on P2X4 channels.
We tested for voltage dependence for the action of IVM, as
Figure 1. IVM potentiates P2X4 but not P2X2 or P2X3
channel currents. A, Representative recordings of currents
mediated by P2X4 channels expressed in oocytes. Left
trace, 100 mM ATP-evoked current before and after (right
trace) addition of IVM (10 mM); IVM potentiates the
amplitude as well as duration of the ATP-evoked current.
B, Representative recordings for P2X2 channels expressed
in oocytes. Left trace, 100 mM ATP-evoked current before
and after (right trace) addition of IVM (10 mM); IVM
causes no change in either the holding current or ATP-
evoked current in P2X2-expressing cells. C, Summary of
data from a number of cells (n . 5 for each) showing that
IVM (10 mM) potentiates ATP-evoked currents at P2X4
channels but not at P2X2 , P2X3 , and P2X2 /P2X3 channels.
D, Summary of data from a number of cells (n . 5 for
each) showing that suramin (30 mM) can block ATP-
evoked currents at P2X2 , P2X3 , and P2X2 /P2X3 channels
but not at P2X4 channels. Subsequent figures show a more
pronounced potentiation of P2X4 channels at lower IVM
and/or ATP concentrations. The data are derived from
measurements of peak ATP-evoked currents.
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would be expected if its site of action were inside the pore. The
data show that IVM does not cause any shift in the reversal
potential of the ATP-evoked current–voltage relationship and
that the IVM potentiation occurs at all membrane voltages (2120
to 1 60 mV with 3 mM IVM and 10 or 100 mM ATP; Fig. 2E).
Figure 2F shows these data plotted as a ratio of the IVM-
potentiated current to the ATP-evoked current alone versus
membrane potential. Although the potentiating effect of IVM
clearly occurs at all membrane potentials, it does in addition
display weak voltage dependence; the effect is smaller at voltages
negative to 260 mV than at voltages more positive than this.
In addition to increasing the peak current mediated by P2X4
channels, IVM also increased the decay time of the ATP-evoked
currents at P2X4 channels by ;30-fold (Fig. 3A,C). This suggests
that IVM increases the affinity of P2X4 channels for ATP, and
that once bound in the presence of IVM, ATP dissociates slowly
from the channel. Alternatively P2X4 channels may be less likely
to enter a desensitized state after IVM application. We also
determined the effect of IVM on total charge transfer during
ATP-evoked currents; this was increased markedly (36 6 8-fold)
by IVM from 4.1 6 0.8 mC in control to 149 6 37 mC with IVM.
There was no change in membrane capacitance (Fig. 3D) during
IVM application, suggesting that the effect of IVM on the peak
ATP-evoked currents is probably not attributable to the insertion
of vesicles containing a new population of P2X4 channels. Instead
the increase in peak ATP-evoked current, slowing of deactiva-
tion, and decrease in EC50 for ATP are most readily explained by
modulation of the existing population of P2X4 channels.
The ATP analog a,b-methylene-ATP is a weak agonist at P2X4
channels, producing ,10% of the current evoked by ATP (Fig.
4A) even at high concentrations (Buell et al., 1996; Seguela et al.,
1996; Michel et al., 1997; Le et al., 1998a), indicating that it is a
low-efficacy agonist (Colquhoun, 1998). An allosteric effector acts
independently of the agonist binding site and would therefore be
expected to affect both ATP and a,b-methylene-ATP responses.
Indeed, IVM (3 mM) increased the inward current evoked by 30
mM a,b-methylene-ATP significantly from 215 6 6 nA with
a,b-methylene-ATP alone to 2357 6 147 nA for a,b-methylene-
ATP plus IVM (n 5 5); on the same occasions as these experi-
ments were performed, IVM (3 mM) increased the current evoked
by ATP (30 mM) from 2273 6 75 to 2857 6 284 nA (n 5 5).
These data prompted us to investigate the action of IVM (3 mM)
on the concentration–effect relationship of a,b-methylene-ATP.
IVM converted a,b-methylene-ATP from a weak agonist with an
EC50 of .300 mM to a more potent agonist, one with an EC50 of
19 mM (Fig. 4A), and thus provides direct evidence for allosteric
modulation of P2X4 channels by IVM.
Figure 2. Properties of the IVM potentiation of P2X4
channel currents. A, Time course of potentiation by IVM.
IVM was added at t 5 0, just after the first puff of ATP (3
mM). Potentiation by IVM occurs within 15 sec (time of the
second ATP pulse) and is maximal by 30 sec. B, The oocyte
was exposed once to ATP (3 mM) in the absence of IVM
(t 5 25 min). Fifteen seconds later, IVM was applied for
5 min. At t 5 0, a second ATP application evoked a greater
than fourfold larger ATP response. Thus the ATP-evoked
current is potentiated in the absence of ATP, showing that
IVM action is use-independent. After washout of IVM,
the ATP-evoked current returns to baseline levels within
10–20 min. For A and B the period of IVM application is
shown by the horizontal bar, and the bold line is an expo-
nential fit to the data. C, Concentration dependence of
IVM action, tested with pulses of 1 mM ATP. IVM causes
significant potentiation at concentrations $0.1 mM. The
superimposed heavy line represents a fitted curve (Hill
equation) with an EC50 of 257 nM and a Hill coefficient of
1; note, however, that the IVM potentiation decreases at 10
mM. D. Concentration–effect relationship for ATP in the
absence (F) and presence (E) of 3 mM IVM. IVM both
increases the maximal current and decreases the EC50 for
ATP. E, Leak-subtracted current–voltage relationships for
the ATP-evoked current in the absence (F) and presence
(E) of 3 mM IVM; note that there is no shift in the reversal
potential. F, Data from experiments like that shown in D.
The ratio of the IVM potentiated current to that of the
ATP-evoked current alone is plotted versus the membrane
voltage. IVM can potentiate the ATP-evoked current at all
membrane voltages tested; in addition, the potentiation is
slightly greater at positive voltages. For this figure the data
are plotted as mean 6 SEM.
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Channels formed by co-expression of P2X4 and
P2X6 channels
We found no evidence for ATP-evoked or a,b-methylene-ATP-
evoked currents at homomeric P2X6 channels expressed in oo-
cytes (with or without 3 mM IVM), and this indicates that P2X6
channels are nonfunctional in oocytes (also see Le et al., 1998a).
However, in agreement with previous data when P2X4 and P2X6
channels were co-expressed, we observed a,b-methylene-ATP-
evoked currents with a threshold concentration of 10 mM, and
EC50 of 25 mM (Table 1). The heteromeric P2X4/P2X6 channel
displays a phenotype distinct from either P2X4 or P2X6 channels
alone (Le et al., 1998a); in particular, the threshold concentration
for a,b-methylene-ATP at P2X4 channels was 300 mM (Fig. 4A,
Table 1), indicating that the heteromer formed by co-expression
of P2X4 and P2X6 channels has a higher sensitivity to a,b-
methylene-ATP than does homomultimeric P2X4 alone (Le et al.,
1998a). We next tested the action of 3 mM IVM in cells expressing
P2X4/P2X6 channels. In the most important observation, IVM
decreased the a,b-methylene-ATP threshold concentration from
10 to 3 mM (Fig. 4B, asterisk). Because homomeric P2X4 channels
do not respond detectably to 3 mM a,b-methylene-ATP, this
observation suggests—but does not prove—that IVM also poten-
tiates a distinct receptor species, presumably the P2X4/P2X6
receptor.
In oocytes co-injected with P2X4 and P2X6 mRNA, IVM also
potentiated agonist-evoked currents at a,b-methylene-ATP con-
centrations .10 mM and decreased the EC50 from 25 to 16 mM
(Table 1). These IVM actions could arise via effects at homo-
meric P2X4 channels that may also be present in the oocytes (Fig.
4, Table 1) and are therefore less convincing than the differences
in threshold a,b-methylene-ATP concentration.
IVM modulates only the I1 states of P2X4 channels
Recent data show that P2X4 channels display biphasic currents
during prolonged ATP applications in Na1 solutions (Fig. 5, I1,
I2). The second phase is attributable to a history-dependent
increase in permeability (Khakh et al., 1999; Virginio et al.,
1999). We tested whether IVM modulates both I1 and I2, and
found that only the initial ATP-evoked current (I1, 10–20 sec
ATP applications), is potentiated (Fig. 5). This provides further
evidence that I2 occurs independently of the magnitude of inward
current during I1 (Khakh et al., 1999). However, it remained
possible that the potentiated I1 current was in fact caused by a
recruitment of some channels from the I2 state, such that they now
opened with brief ATP applications. To address this directly, we
determined NMDG1 permeability ratios for the control and
IVM-potentiated currents, because NMDG1 is substantially per-
meable during the I2 current, and is only weakly permeable
during I1. The reversal potential for ATP-evoked current alone
(I1) was 250.5 mV, whereas that for the IVM-potentiated current
was 247.9 mV (see Fig. 5; n 5 5). In comparison, the reversal
potential for I2 is typically 230 mV (Khakh et al., 1999). The
pNMDG1/pNa1 ratios for control ATP-evoked currents and the
IVM-potentiated currents were identical (Fig. 5D). This indicates
that control currents and IVM-enhanced currents have equally
low permeability to NMDG1. Therefore, the previously reported
low-selectivity I2 state (Khakh et al., 1999) does not contribute
detectably to the IVM-potentiated current; IVM potentiates only
I1. The mechanism(s) of ion selectivity changes are not fully
understood but likely involve structural rearrangements in the
permeation pathway (Khakh et al., 1999; Virginio et al., 1999).
We presume that IVM binds less strongly to the I2 state than to
the I1 state or does not enhance the conformational change that
leads to opening of this state. This extends previous findings
demonstrating that the distinct selectivity states of P2X7 channels
can be probed differentially by blockers (for review, see Ralevic
and Burnstock, 1998).
Allosteric modulation in a clonal mammalian cell line
To circumvent desensitization we applied ATP every 2 min to
HEK 293 cells transfected with P2X4 channels. After three doses
of ATP we applied IVM (3 mM) for 4 min and repeated the ATP
applications. These experiments show that IVM can augment
ATP-evoked currents in P2X4-transfected mammalian cells. The
peak effect and kinetics resemble those observed for IVM action
in oocytes, demonstrating that the effect of IVM on P2X4 chan-
nels is independent of the host cell (Fig. 6; top graph is from a
single HEK 293 cell; bottom graph is an average from four such
cells).
Brainstem and hippocampal neurons expressing
P2X channels
The brainstem MNV contains proprioceptive neurons that ex-
press transcripts for P2X4, P2X5, and P2X6 (Collo et al., 1996);
P2X responses are recorded on MNV neuron somata and central
terminals (Cook et al., 1997; Khakh et al., 1997; Khakh and
Henderson, 1998a). In agreement with these studies, ATP (50
mM) puffed directly onto the somata evoked inward currents in
these neurons, but IVM (5 mM) did not affect these ATP-evoked
currents (,5% change; n 5 3; Fig. 7). These data provide further
evidence that the P2X channels in MNV neurons do not com-
prise homomeric P2X4 channels and thus extend previous find-
ings using electrophysiological approaches (Cook et al., 1997;
Khakh et al., 1997).
Figure 3. IVM affects P2X4 deactivation kinetics but neither basal cur-
rent nor membrane capacitance. A, Representative recording showing
that IVM produces a large increase in P2X4 channel current evoked by 3
mM ATP, although IVM produces no change in the holding current. B–D,
Bar graphs showing summary of ATP-evoked current properties from
cells recorded in the experiment shown in A. B, peak response; C,
deactivation half-time; D, cell capacitance.
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Recent studies in CA1 pyramidal neurons have demonstrated
rapid ATP-evoked currents and fast ATP synaptic transmission
(Pankratov et al., 1998; Proctor and Dunwiddie, 1998), but the
identity of the P2X channels in CA1 neurons is uncertain, in part
because they express many mRNA species, including P2X4 (Collo
et al., 1996). If IVM could modulate the ATP-evoked currents in
these neurons, this might indicate the presence of homomeric
P2X4 or possibly P2X4-containing channels. However, when re-
sponses to locally applied ATP were recorded from identified
hippocampal CA1 pyramidal neurons, ATP-evoked currents in
the majority of neurons were unaffected by IVM (13 of 13
neurons responded to ATP, but 10 of these 13 did not respond to
IVM; Fig. 7). A potential concern in these experiments was the
possibility that IVM does not penetrate brain slices effectively.
However, in parallel experiments we found that 2 mM IVM
markedly potentiated fast GABAA channel currents evoked by
puffing GABA on to CA1 neurons; the effect of IVM was both
rapid and reversible (n 5 3), suggesting that IVM does in fact
penetrate brain slices. In three neurons we observed larger ATP-
evoked currents in the presence of IVM than in control. However
when the data from all 13 cells were averaged, the increase was
not significant (174 6 85% of control). To gain further insight as
to the nature of the P2X channels expressed on CA1 neurons and
to allow comparison with other neurons, we next tested the action
of a,b-methylene-ATP. a,b-Methylene-ATP is a weak agonist at
homomeric P2X4 channels (Fig. 4A) but is a potent agonist at
known CNS heteromeric channels (Le et al., 1998a; Torres et al.,
1998); it is known to activate P2X channels that are endogenously
expressed in neurons, some of which are most likely heteromeric
assemblies [e.g., sensory neurons (Chen et al., 1995; Khakh et al.,
1995a; Lewis et al., 1995; Cook et al., 1997), medial habenula
neurons (Edwards et al., 1992), and locus coeruleus neurons
(Nieber et al., 1997)]. When we puffed a,b-methylene-ATP (50
mM) onto CA1 neurons we observed large fast inward currents
(298 6 19 pA; six of six neurons). This observation, in combi-
nation with the lack of effect of IVM on most cells, provides the
first functional evidence to indicate that homomeric P2X4 chan-
nels are not expressed in the majority of adult hippocampal CA1
region neurons, despite the fact that in situ hybridization studies
show that their transcripts are abundant here (Buell et al., 1996;
Figure 4. Effect of a,b-methylene-ATP on
homomeric P2X4 and heteromeric P2X4 /
P2X6 channels. A, P2X4 channels: concentra-
tion–effect curves for a,b-methylene-ATP in
the absence and presence of 3 mM IVM. Right
graphs, Same data on an expanded current
scale. B, Co-expression of P2X4 /P2X6 chan-
nels: concentration–effect curves for a,b-
methylene-ATP in the absence and presence
of 3 mM IVM. Right graphs, Same data on an
expanded current scale. The asterisks indicate
the threshold concentration for a,b-methylene-
ATP (see Table 1).
Table 1. Properties of a,b-methylene-ATP concentration–effect curves with and without IVM on P2X4
receptors alone or when expressed in combination with P2X6 receptors
Receptor a,b-Methylene-ATP Threshold (mM) EC50 (mM) Hill slope Imax (2nA)
a n
P2X4 Control 300 .300
b 433 6 113 7
1IVM (3 mM) 10 19.8 6 3.7 2.0 6 0.2 1608 6 311 6
P2X4/P2X6 Control 10 25.1 6 2.7* 1.8 6 0.3 360 6 50 8
1IVM (3 mM) 3 15.6 6 1.4* 2.2 6 0.1 3739 6 244 9
aImax is the largest current on the concentration–effect curve to a,b-methylene-ATP (100 or 300 mM).
bThe Hill slope was not possible to determine.
*Statistical difference (at p , 0.05) between these two EC50 values ( p 5 0.005; unpaired Student’s t test; also see Figure 4
for graphs).
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Collo et al., 1996); overall this supports and extends previous
findings using immunocytochemistry (Le et al., 1998a).
Conclusions about the lack of effect of IVM against ATP-
evoked currents in brain slice neurons would be invalid if for
unknown reasons IVM does not modulate P2X4 channels when
expressed in neurons. To address this directly we transfected
embryonic hippocampal neurons with P2X4 and used EGFP as a
transfection reporter. Untransfected neurons show no ATP-
evoked responses (Fig. 8C,D, top; 0.1–1 mM ATP), consistent with
in situ hybridization studies showing minimal levels of P2X4
transcripts in the embryonic hippocampus (Buell et al., 1996). We
used the presence of EGFP fluorescence (24–48 hr after trans-
fection) to identify transfected neurons; such neurons responded
with large ATP-evoked inward currents or membrane depolar-
izations (Fig. 8C,D). We next tested the action of IVM (3 mM) on
ATP-evoked currents in transfected hippocampal neurons, and
IVM markedly augmented the ATP-evoked currents in all neu-
rons tested (Fig. 8E,F). These experiments provide direct evi-
dence that IVM can modulate P2X4 channels when expressed in
neurons and allow unambiguous interpretation of the data show-
ing little effect of IVM on neurons in hippocampal slices (see
above and Fig. 7).
DISCUSSION
The main finding of the present study is that IVM can augment
ATP-evoked currents at homomeric P2X4 channels, and possibly
P2X4/P2X6 channels, by an allosteric mechanism.
Figure 6. IVM potentiates P2X4 channel currents in a clonal mammalian
cell line. Top panel, Amplitudes of ATP (10 mM)-evoked currents from a
single HEK 293 cell; ATP was applied every 2 min and IVM (3 mM) was
added for the period indicated. The sample traces at the right were elicited
from this cell at the time points indicated. Bottom panel, Averaged data
from four such cells tested with the same protocol.
Figure 5. IVM potentiates the high-selectivity (I1) but not the low-selectivity (I2) state of the P2X4 channel. A, Representative 3 mM ATP-evoked
current from an oocyte expressing P2X4 channels; the solid bar indicates the period of ATP application. B, Representative recording of a 3 mM
ATP-evoked current during exposure to IVM (3 mM). C, Bar graph summarizing data from experiments such as those illustrated in A and B from seven
cells; only I1 is potentiated. D, Table showing reversal potentials for control and IVM-potentiated I1 in both Na
1 and NMDG 1 solutions, as well as the
ratio of NMDG 1 to Na 1 permeability (n 5 5). The NMDG 1 reversal potential for I2 is typically 230 mV (Khakh et al., 1999).
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Functional sequelae of P2X4 channel allosterism
IVM is an agonist at glutamate-gated chloride channels of inver-
tebrates (Cully et al., 1994) and is a positive allosteric effector of
GABAA and a7 nicotinic channels (Krusek and Zemkova, 1994;
Krause et al., 1998). These ligand-gated channels all belong to the
four transmembrane domains per subunit superfamily (Krusek
and Zemkova, 1994; Krause et al., 1998). In contrast, the P2X
channels are unrelated to these channels both at the level of
amino acid sequence and protein topology (North, 1996). At
present the binding site for IVM on any ion channel is unknown;
sequence comparisons among P2X4 channels, glutamate-gated
chloride channels, or a7 nicotinic channels reveal no real clues.
Nevertheless, IVM is most likely acting on P2X4 channels them-
selves and not on components that are endogenous to oocytes,
such as calcium-activated chloride channels, for two reasons.
First, the effect of IVM was specific to P2X4 and possibly P2X4/
P2X6 channels; P2X2, P2X3, P2X2/P2X3, or P2X7 channels were
unaffected, although these channels are also calcium-permeable.
The evidence for potentiation of P2X4/P2X6 channels is not
decisive. Second, the kinetics and degree of potentiation for IVM
were similar in oocytes, HEK-293 cells, and embryonic hip-
pocampal neurons, clearly demonstrating that the effect of IVM
is independent of the host cell in which P2X4 channels are
expressed. The present results demonstrate that IVM specifically
increases ATP-evoked currents mediated by P2X4 channels and
suggest that P2X4 channels contain an allosteric binding site for
IVM. IVM does not markedly affect ATP-evoked currents me-
diated by other P2X subunits expressed in oocytes, such as the
P2X2 channels, which are found in the central and peripheral
nervous systems (for review, see Ralevic and Burnstock, 1998),
P2X3 channels, which are abundant in pain sensors (Chen et al.,
1995; Lewis et al., 1995; Cook et al., 1997), or P2X7 channels,
which are found in immune cells (Nuttle and Dubyak, 1994;
Surprenant et al., 1996; Collo et al., 1997). Thus, IVM may be a
useful pharmacological tool that can discriminate central P2X4
from other P2X channels.
Previously, radioligand-binding studies have suggested that
ATP binding to P2X4 channels can be modulated allosterically
(Michel et al., 1997). By using IVM we (1) identify a novel
chemical structure that specifically probes P2X4 channels, (2)
characterize the effects of this modulation on the properties of
P2X4 channels, and (3) show that P2X4 channel modulation by
IVM is by an allosteric mechanism. In agreement with published
functional studies that show suramin to be ineffective at P2X4
channels (Buell et al., 1996; Seguela et al., 1996; Soto et al., 1996),
we find no evidence to show that suramin can modulate P2X4
channel currents.
An allosteric action of IVM on P2X4 is supported by the
observations that IVM rarely produced a change in the holding
current by itself but potentiated the current evoked by ATP and
Figure 7. Endogenous P2X channels in MNV and hip-
pocampal CA1 neurons. A, Bright-field image of a brain-
stem slice containing the MNV. MNV neurons can be
seen as round neurons. Scale bar, 10 mm. B, Image of the
CA1 region in a hippocampal slice. CA1 pyramidal neu-
rons can be seen extending a dendrite into the stratum
radiatum. Scale bar, 10 mm. C, Representative ATP-
evoked currents from an MNV neuron. D, Representative
traces of ATP-evoked currents from a CA1 neuron. In
both cases recordings in the presence of 2–5 mM IVM are
also shown. The bar graph represents average values for
MNV neurons (n 5 3), whereas the scatter graph shows
data for nonresponding CA1 neurons (E), the three re-
sponding neurons (f; arrows), and the average for all 13
neurons (F).
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slowed its deactivation. The ATP analog a,b-methylene-ATP is a
weak agonist at P2X4 channels (Buell et al., 1996) and evokes
;10% of the current evoked by ATP at similar concentrations.
Interestingly, however, a,b-methylene-ATP and ATP both bind
with relatively high affinity to P2X4 channels (Michel et al., 1997),
suggesting that the low-potency a,b-methylene-ATP in functional
experiments may be attributable to a lower intrinsic efficacy or a
lower ability to gate the channel once bound. In the presence of
IVM, a,b-methylene-ATP becomes a potent agonist, another
familiar property of allosteric effectors. If further experiments
lead to knowledge about the binding site and mechanisms of
allosterism by IVM, this will be a useful approach to study the
events leading to P2X channel gating after ATP binding.
Responses in neurons
Having established the specificity of IVM as an allosteric effector
of P2X4 channels in oocytes, HEK cells, and embryonic hip-
pocampal neurons, we next tested its actions in adult brain neu-
rons that express mRNA transcripts for P2X4. Our initial goal was
to determine whether homomeric P2X4 channels are expressed in
these neurons. In the brainstem MNV we found that IVM did
not affect ATP-evoked currents, and this is consistent with pre-
vious conclusions that the P2X channels in MNV neurons are
most like P2X5 (Cook et al., 1997) or a combination of P2X
channels (Khakh et al., 1997). The CA1 field of the hippocampus
is abundant in P2X4 mRNA, and previous investigators therefore
suggested that homomeric P2X4 channels might be expressed in
these cells (Buell et al., 1996; Collo et al., 1996). To our surprise,
IVM did not affect ATP-evoked currents in these neurons, sug-
gesting that homomeric P2X4 channels are not located on the
soma of pyramidal cells, but functional activity of these channels
on the dendrites was not tested. To the extent that our data
suggest that heteromeric P2X4/P2X6 channels are also potenti-
ated by IVM, we may conclude that such channels are also not
expressed in these cells. It is possible that the endogenous P2X
channels in CA1 comprise (1) other heteromeric P2X channels,
(2) a mixed population of P2X channels, or (3) a new P2X channel
and/or (4) that homomeric P2X4 channels are found in only a
subset of CA1 neurons. The marked enhancement of responses in
a small fraction of hippocampal neurons (Fig. 7F) is consistent
with this last conclusion, but further studies are needed to dis-
criminate between these four possibilities. Known heteromeric
P2X channel assemblies are activated by a,b-methylene-ATP,
and it has been proposed that they may constitute some of the
P2X channels found in the CNS, possibly including those in the
Figure 8. P2X4 channels expressed in embryonic hip-
pocampal neurons. A, B, Bright-field ( A) and fluorescence
(B) image of embryonic hippocampal neurons transfected
with plasmids for P2X4 and EGFP. Note that the morphol-
ogy of transfected and nontransected neurons is very sim-
ilar, and this appearance is typical of healthy cells. The
extended fluorescent cells in B are glial cells. C, Top trace,
Representative voltage-clamp currents recorded from an
untransfected neuron showing no ATP-evoked currents
(holding potential, 260 mV); bottom trace, large ATP-
evoked currents in a transfected hippocampal neuron. D,
Top trace, Representative current-clamp recording (resting
potential, 252 mV) from an untransfected neuron showing
no ATP-evoked change in membrane potential; bottom
trace, large ATP-evoked depolarization in a transfected
hippocampal neuron. Action potentials have been clipped.
E, Representative traces from a transfected hippocampal
neuron showing 10 mM ATP-evoked currents before and
after 3 mM IVM application. F, Summary of experiments
such as those illustrated in E from six neurons. Note that
the size of the ATP-evoked current varies markedly be-
tween neurons, but in all neurons IVM potentiates the
current.
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hippocampus (Le et al., 1998a; Torres et al., 1998, 1999). This
proposal is supported by data showing overlapping distribution of
many P2X subunit mRNAs throughout the nervous system (Collo
et al., 1996). Interestingly, recent data from the CA1 region of the
hippocampus also show that the P2X channels can be activated by
a,b-methylene-ATP (this study) and partially blocked by antago-
nists (Pankratov et al., 1998; Proctor and Dunwiddie, 1998).
These properties, along with the insensitivity to IVM, suggest
that the predominant ATP-evoked current (Pankratov et al.,
1998) in the CA1 of the hippocampus is mediated by neither
homomeric P2X4 nor heteromeric P2X4/P2X6 channels but
rather by channels with properties that may be most similar to
those described for other heteromeric channels (Lewis et al.,
1995; Le et al., 1998a; Torres et al., 1998, 1999). The P2X4
message is not restricted to the hippocampus and is found in
many brain areas (Collo et al., 1996); it remains to be determined
whether some of these neuron subsets do indeed express homo-
meric P2X4 channels.
Allosteric modulators of other ligand-gated ion channels have
become important experimental tools to determine the contribu-
tion of distinct channel types to the function of brain synapses.
P2X2 and P2X3 receptors are modulated by cations such as Zn
21,
H1, and Ca21, and it is possible that such modulation has a
physiological role as well (King et al., 1997; Stoop et al., 1997;
Wildman et al., 1997, 1998; Cook et al., 1998). The lack of
pharmacological probes for P2X4 channels has hindered under-
standing of their function, but in the present study we have
identified IVM as the first agent that discriminates P2X4 from
other P2X channels. Remarkably, IVM can increase the gating
efficiency and slow the deactivation kinetics of ATP at P2X4
channels, suggesting that the open probabilities of P2X4 channels
increase in the presence of IVM. Overall IVM evokes a profound
gain-of-function phenotype in P2X4 channels. It remains to be
determined whether the site on the P2X4 protein that IVM
probes is also the target for an endogenous allosteric effector.
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